17-Nov-2021
The Independent
There is evidence of a potential conflict between the CPTPP and the UK’s current system of market authorisation of generic and biosimilar drugs.
20-Sep-2021
Socialist Project
Transnational companies today rely more than ever on IPR to structure their global value chains, writes Peter Rossman
8-Sep-2021
Globalization and Health
Given the potential for wider use of the ISDS mechanism, strategies to protect public health policy space in the context of both international trade and investment treaty and dispute settlement contexts remain important.
14-Jul-2021
Globalization and Health
This paper examines civil society and health actors’ views of the conditions that successfully contributed to the removal of these measures in RCEP, with a focus on intellectual property and access to medicines.